![Donald Lee Drakeman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Lee Drakeman
Directeur Général chez
GenPharm International LLC
Profil
Donald Lee Drakeman was the founder of Genmab A (1998) and Medarex, Inc. (1987) where the title held was President & Chief Executive Officer from 1987 to 2006.
Current jobs include President & Chief Executive Officer at GenPharm International LLC, Chairman at New Jersey Commission on Science & Technology, Director at Gem Pharmaceuticals LLC, and Venture Partner at Advent Venture Partners LLP since 2007.
Former jobs include Chairman at Celldex Therapeutics, Inc. (Old), Independent Director at Zymeworks BC, Inc., Director-Executive Board at 4-Antibody AG, Director at IDM Pharma, Inc., and Faculty Member at Princeton University.
Education includes a graduate degree from The Trustees of Columbia University in The City of New York (1979), an undergraduate degree from Dartmouth College (1975), and a doctorate from Princeton University (1988).
Postes actifs de Donald Lee Drakeman
| Sociétés | Poste | Début |
|---|---|---|
GenPharm International LLC
 GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Directeur Général | - |
New Jersey Commission on Science & Technology
 New Jersey Commission on Science & Technology General GovernmentGovernment Engages in development and oversight of policies and programs promoting science and technology research and entrepreneurship | Président | - |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/01/2007 |
Gem Pharmaceuticals LLC
 Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company develops proprietary anthracycline derivatives | Directeur/Membre du Conseil | - |
Anciens postes connus de Donald Lee Drakeman
| Sociétés | Poste | Fin |
|---|---|---|
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Directeur/Membre du Conseil | 01/06/2007 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Directeur Général | 05/11/2006 |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| GENMAB A/S | Fondateur | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur/Membre du Conseil | - |
Formation de Donald Lee Drakeman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
New Jersey Commission on Science & Technology
New Jersey Commission on Science & Technology General GovernmentGovernment Engages in development and oversight of policies and programs promoting science and technology research and entrepreneurship | Government |
Gem Pharmaceuticals LLC
Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company develops proprietary anthracycline derivatives | Health Technology |
